Logo Logo
Hilfe
Hilfe
Switch Language to English

Nagler, Arnon; Dholaria, Bhagirathbhai; Labopin, Myriam; Savani, Bipin N.; Angelucci, Emanuele; Koch, Yener; Arat, Mutlu; Pioltelli, Pietro; Sica, Simona; Gulbas, Zafer; Tischer, Johanna; Bernasconi, Paolo; Pavlu, Jiri; Socie, Gerard; Blaise, Didier; Rigacci, Luigi; Martino, Massimo; Diez-Martin, Jose Luis; Peric, Zinaida; Giebel, Sebastian und Mohty, Mohamad (2020): Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia. In: Leukemia, Bd. 34, Nr. 10: S. 2766-2775

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

The ideal stem cell graft source remains unknown in haploidentical haematopietic cell transplantation (haplo-HCT) with posttransplantation cyclophosphamide (PTCy). This study compared outcomes of bone marrow (BM) versus peripheral blood (PB) stem cell graft for haplo-HCT in acute lymphoblastic leukemia (ALL). A total of 314 patients with ALL (BM-157;PB-157) were included in this study. The cumulative incidence of engraftment at day 30 was higher in the PB group compared with BM (93% vs. 88%, p < 0.01). The incidences of acute graft-versus-host disease (GVHD) and chronic GVHD were not significantly different between the study cohorts. In the multivariate analysis, there were tendencies toward a higher incidence of grade II-IV acute GVHD (hazard ratio (HR) = 1.52, p = 0.07), chronic GVHD (HR = 1.58, p = 0.05), and nonrelapse mortality (NRM) (HR = 1.66, p = 0.06) in patients receiving PB versus BM graft, respectively. The use of PB grafts was associated with lower leukemia-free survival (LFS) (HR = 1.43, p = 0.05), overall survival (OS) (HR = 1.59, p = 0.02), and GVHD-free, relapse-free survival (GRFS) (HR = 1.42, p = 0.03) compared with BM grafts. There was no difference in relapse incidence (HR = 1.23, p = 0.41) between the study groups. In conclusion, use of BM graft results in better survival after haplo-HCT with PTCy in patients with ALL, compared with PB stem cell graft.

Dokument bearbeiten Dokument bearbeiten